Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.
about
Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a reviewThe Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?Preliminary evidence for associations of CHRM2 with substance use and disinhibition in adolescence.The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.The anterior cingulate cortex may enhance inhibition of lateral prefrontal cortex via m2 cholinergic receptors at dual synaptic sites.The association of white matter volume in psychotic disorders with genotypic variation in NRG1, MOG and CNP: a voxel-based analysis in affected individuals and their unaffected relativesMultiple Nicotinic Acetylcholine Receptor Subtypes in the Mouse Amygdala Regulate Affective Behaviors and Response to Social Stress.Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants.Human biomarkers of rapid antidepressant effectsDRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder.Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity.Biological hypotheses and biomarkers of bipolar disorder.Synthesis and in vitro evaluation of novel nortropane derivatives as potential radiotracers for muscarinic m(2) receptorsA Genome-Wide Association Study and Complex Network Identify Four Core Hub Genes in Bipolar Disorder.Role of 108 schizophrenia-associated loci in modulating psychopathological dimensions in schizophrenia and bipolar disorder.
P2860
Q26822244-4AF48820-DB92-4538-9DD5-76097E5DF0D8Q28082434-4A77EEF1-5D0C-4A72-AC9B-A103425BCC31Q34626957-94B95493-2B18-4162-B8B3-191BB7723C1FQ35054681-38746EA2-8EE5-483F-88BD-03748C61BEBFQ36469220-3A94B796-2A56-476B-9180-01373DE25F54Q36591384-F2C0FF44-BDFC-4A52-B732-66D90BA24BB8Q36799026-2E6F2339-A3D0-4A6A-B5D5-6B2C3A7F7C9FQ36852394-86F3054E-97D6-4840-B7A8-FCAA6F6A6E45Q36902074-36081C67-2DF9-4677-B452-76501B40556EQ37136220-A0394EBA-3B5B-4B3D-A71E-FDC378CC5FC2Q38086422-9814C776-736A-4C36-9D6A-9E8709426679Q38995726-B8E4BEE6-FAFB-4502-A89A-B424BCA4D34EQ42792056-45684BAB-C04F-486A-B25D-B0A3EB7CB249Q47276840-B9FEE4BB-87C0-48F3-B195-BAB68256AA82Q47803547-BE153FB8-8021-49BB-92DB-DA261BB239B8
P2860
Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Genetic variation in cholinerg ...... d binding in bipolar disorder.
@ast
Genetic variation in cholinerg ...... d binding in bipolar disorder.
@en
type
label
Genetic variation in cholinerg ...... d binding in bipolar disorder.
@ast
Genetic variation in cholinerg ...... d binding in bipolar disorder.
@en
prefLabel
Genetic variation in cholinerg ...... d binding in bipolar disorder.
@ast
Genetic variation in cholinerg ...... d binding in bipolar disorder.
@en
P2093
P2860
P50
P356
P1433
P1476
Genetic variation in cholinerg ...... ed binding in bipolar disorder
@en
P2093
J K Klaver
K Erickson
S K Gandhi
W C Drevets
W C Eckelman
P2860
P2888
P304
P356
10.1038/MP.2010.24
P407
P577
2010-03-30T00:00:00Z